newsfilter
← Latest News
Business Wire·

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

Expanded platform delivers patient insights across six new clinical scenarios in breast, colorectal, ovarian, prostate, and urothelial cancers Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of